{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:08:10Z","timestamp":1792800490014,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yeolin medical foundation","award":["YMF-2023-01"],"award-info":[{"award-number":["YMF-2023-01"]}],"id":[{"id":"https:\/\/ror.org\/02zfaen51","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04520-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:37:37Z","timestamp":1760621857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a predictive model for nafamostat mesylate dosing in hemodialysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-4802","authenticated-orcid":false,"given":"Shin Yeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-8715","authenticated-orcid":false,"given":"Jin Sug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4323-6466","authenticated-orcid":false,"given":"Hwa Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9731-0097","authenticated-orcid":false,"given":"Jeong Min","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5476-606X","authenticated-orcid":false,"given":"Moon Jeong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7709-1680","authenticated-orcid":false,"given":"Ji Yung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1958-6019","authenticated-orcid":false,"given":"Kyung-A","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4158-0569","authenticated-orcid":false,"given":"Kyun Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1119-1649","authenticated-orcid":false,"given":"Ah Ran","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8013-7863","authenticated-orcid":false,"given":"Sung Min","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3604-5448","authenticated-orcid":false,"given":"Kyoung Hwa","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-8792","authenticated-orcid":false,"given":"Hae Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"4520_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/01.ASN.0000043900.39397.48","volume":"14","author":"K Iwashita","year":"2003","unstructured":"Iwashita K, Kitamura K, Narikiyo T, et al. Inhibition of prostasin secretion by Serine protease inhibitors in the kidney. J Am Soc Nephrol. 2003;14:11.","journal-title":"J Am Soc Nephrol"},{"key":"4520_CR2","doi-asserted-by":"publisher","first-page":"6618","DOI":"10.3390\/jcm12206618","volume":"12","author":"TM Seccia","year":"2023","unstructured":"Seccia TM, Shagjaa T, Morpurgo M, et al. Randomized clinical trial of Nafamostat mesylate, a potent transmembrane protease Serine 2 (TMPRSS2) inhibitor, in patients with COVID-19 pneumonia. J Clin Med. 2023;12:6618.","journal-title":"J Clin Med"},{"key":"4520_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4266\/acc.2021.01312","volume":"37","author":"JH Lee","year":"2022","unstructured":"Lee JH, Park JH, Jang JH, et al. The role of Nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation. Acute Crit Care. 2022;37:177\u201384.","journal-title":"Acute Crit Care"},{"key":"4520_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.23876\/j.krcp.21.600","volume":"40","author":"JY Jung","year":"2021","unstructured":"Jung JY, Yoo KD, Kang E, Korean Society of Nephrology Clinical Practice Guideline Work Group, et al. Korean society of nephrology 2021 clinical practice guideline for optimal Hemodialysis treatment. Kidney Res Clin Pract. 2021;40:S1\u201337.","journal-title":"Kidney Res Clin Pract"},{"key":"4520_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1159\/000187357","volume":"64","author":"T Akizawa","year":"1993","unstructured":"Akizawa T, Koshikawa S, Ota K, Kazama M, Mimura N, Hirasawa Y. Nafamostat mesilate: a regional anticoagulant for Hemodialysis in patients at high risk for bleeding. Nephron. 1993;64:376\u201381.","journal-title":"Nephron"},{"key":"4520_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3109\/08860220903180616","volume":"31","author":"JW Yang","year":"2009","unstructured":"Yang JW, Han BG, Kim BR, et al. Superior outcome of Nafamostat mesilate as an anticoagulant in patients undergoing maintenance Hemodialysis with intracerebral hemorrhage. Ren Fail. 2009;31:668\u201375.","journal-title":"Ren Fail"},{"key":"4520_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12998\/wjcc.v12.i1.68","volume":"12","author":"K Liu","year":"2024","unstructured":"Liu K, Li ZH. Efficacy and safety of Nafamostat mesylate in patients with end-stage renal failure. World J Clin Cases. 2024;12:68\u201375.","journal-title":"World J Clin Cases"},{"key":"4520_CR8","doi-asserted-by":"publisher","first-page":"1009748","DOI":"10.3389\/fmed.2022.1009748","volume":"9","author":"M De Troyer","year":"2022","unstructured":"De Troyer M, Wissing KM, De Clerck D, et al. Risk for excessive anticoagulation during Hemodialysis is associated with type of vascular access and bedside coagulation testing: results of a cross-sectional study. Front Med. 2022;9:1009748.","journal-title":"Front Med"},{"key":"4520_CR9","first-page":"920","volume":"23","author":"HC Kim","year":"2004","unstructured":"Kim HC, Han SY, Kim HK, et al. A multi-center phase III clinical trial to assess the influence to bleeding and anticoagulant effect of Nafamostat mesilate in Hemodialysis patients with high bleeding risk. Korean J Nephrol. 2004;23:920\u20136.","journal-title":"Korean J Nephrol"},{"key":"4520_CR10","first-page":"61","volume":"30","author":"EY Kim","year":"2011","unstructured":"Kim EY, Lee YK, Lee SM, et al. Low-dose Nafamostat mesilate in Hemodialysis patients at high bleeding risk. Korean J Nephrol. 2011;30:61\u20136.","journal-title":"Korean J Nephrol"},{"key":"4520_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/ndt\/gft522","volume":"29","author":"T Krummel","year":"2014","unstructured":"Krummel T, Scheidt E, Borni-Duval C, et al. Haemodialysis in patients treated with oral anticoagulant: should we heparinize? Nephrol Dial Transpl. 2014;29:906\u201313.","journal-title":"Nephrol Dial Transpl"},{"key":"4520_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1523-1755.2005.00468.x","volume":"68","author":"F Ziai","year":"2005","unstructured":"Ziai F, Benesch T, Kodras K, Neumann I, Dimopoulos-Xicki L, Haas M. The effect of oral anticoagulation on clotting during Hemodialysis. Kidney Int. 2005;68:862\u20136.","journal-title":"Kidney Int"},{"key":"4520_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ndt\/17.suppl_7.64","volume":"17","author":"Prevention of clotting","year":"2002","unstructured":"Prevention of clotting. In the HD patient with normal bleeding risk. Nephrol Dial Transpl. 2002;17:64\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"4520_CR14","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3390\/ph3123543","volume":"3","author":"H Robert-Ebadi","year":"2010","unstructured":"Robert-Ebadi H, Righini M. Anticoagulation in the elderly. Pharmaceuticals. 2010;3:3543\u201369.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"4520_CR15","first-page":"879","volume":"8","author":"D Kumar","year":"2012","unstructured":"Kumar D, Rizvi SI. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Arch Med Sci. 2012;8(5):879\u201384.","journal-title":"Arch Med Sci"},{"issue":"2","key":"4520_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2133\/dmpk.21.147","volume":"21","author":"S Yamaori","year":"2006","unstructured":"Yamaori S, Fujiyama N, Kushihara M, Arasawa F, Yamashita A, Yamamoto I. Involvement of human blood arylesterases and liver microsomal carboxylesterases in Nafamostat hydrolysis. Drug Metab Pharmacokinet. 2006;21(2):147\u201355.","journal-title":"Drug Metab Pharmacokinet"},{"key":"4520_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1542-4758.2007.00166.x","volume":"11","author":"K Fischer","year":"2007","unstructured":"Fischer K. Essentials of anticoagulation in Hemodialysis. Hemodial Int. 2007;11:178\u201389.","journal-title":"Hemodial Int"},{"key":"4520_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10047-016-0937-2","volume":"20","author":"S Goto","year":"2017","unstructured":"Goto S, Ookawara S, Saito A. Differences in the adsorption of Nafamostat mesilate between polyester-polymer alloy and polysulfone membranes. J Artif Organs. 2017;20:138\u201344.","journal-title":"J Artif Organs"},{"key":"4520_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1744-9987.12587","volume":"21","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Hara S, Hatomoto H, et al. Adsorption of Nafamostat mesilate on AN69ST membranes: a single-center retrospective and in vitro study. Ther Apher Dial. 2017;21:620\u20137.","journal-title":"Ther Apher Dial"},{"issue":"5","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.ackd.2019.08.012","volume":"26","author":"ES Kotzen","year":"2019","unstructured":"Kotzen ES, Roy S, Jain K. Antiphospholipid syndrome nephropathy and other thrombotic microangiopathies among patients with systemic lupus erythematosus. Adv Chronic Kidney Dis. 2019;26(5):376\u201386.","journal-title":"Adv Chronic Kidney Dis"},{"key":"4520_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.37737\/ace.22010","volume":"4","author":"M Iwagami","year":"2022","unstructured":"Iwagami M, Matsui H. Introduction to clinical prediction models. Ann Clin Epidemiol. 2022;4:72\u201380.","journal-title":"Ann Clin Epidemiol"},{"key":"4520_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2288-7-33","volume":"7","author":"MW Heymans","year":"2007","unstructured":"Heymans MW, Van Buuren S, Knol DL, Van Mechelen W, De Vet HC. Variable selection under multiple imputation using the bootstrap in a prognostic study. BMC Med Res Methodol. 2007;7:33.","journal-title":"BMC Med Res Methodol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04520-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:37:39Z","timestamp":1760621859000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04520-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the Bioethics and Safety Act of the Republic of Korea. The study was approved by the Public Institutional Review Board of the Republic of Korea (Approval No. P01-202408-01-011). The requirement for informed consent was waived by the IRB due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"572"}}